Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
about
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseNivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes.Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats.Cellular and molecular mechanisms in graft-versus-host disease.Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies.Immune Checkpoint Blockade and Hematopoietic Stem Cell Transplant.Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.Menopausal status influences the expression of programmed death (PD)-1 and its ligand PD-L1 on immune cells from the human female reproductive tract.Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.Cytokine mediators of chronic graft-versus-host disease.A standardized fold change method for microarray differential expression analysis used to reveal genes involved in acute rejection in murine allograft models.Pembrolizumab and its role in relapsed/refractory classical Hodgkin's lymphoma: evidence to date and clinical utility.Long-term antigen exposure irreversibly modifies metabolic requirements for T cell function.
P2860
Q26751959-17934E23-4FB1-4207-9173-1AC32ADE6B25Q28076264-F71DCF00-1699-4387-9307-B3BBF12BA4DBQ36586109-F30F1D59-7C40-437A-9BD4-A15C783108B5Q36876981-DD3A90C4-1424-41DA-8F5B-3A00E892BE3BQ36985976-F298B7F3-C589-4BEC-866B-CC19F0AF4013Q38661579-860F522E-E87D-425D-8D94-13287910D96DQ38844205-59BD14BF-5E55-483A-84D6-9D4A55D12340Q39116985-0CADAC5E-15EB-40A3-87F1-8FEDFDCEB078Q39161011-AF4BD9C8-DEA9-4CBF-978C-EA00B8CC7571Q40216708-1A379458-D9C9-46DE-9FFF-214BDC49FB7AQ40692283-CFFC980C-002B-43D7-A404-1EE1D8EF5CA2Q42359309-42A95A15-6D17-4CBC-98F9-9BACA3DDC5A3Q48165202-FDFC2285-0410-4ADA-B0D1-867F91B2CDA9Q50915048-450083A7-C147-4BE2-BA36-A6D82D44F6B6Q52670812-91F1CDB5-E219-44BF-A4A8-E0E01DEEFFB1Q52721221-29E33E78-334C-47FF-B624-2DCD4E0267BFQ55425735-132EA48E-E319-4E60-8A1D-F042641C656E
P2860
Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Programmed death-1 pathway in ...... nic graft-versus-host disease.
@en
Programmed death-1 pathway in ...... nic graft-versus-host disease.
@nl
type
label
Programmed death-1 pathway in ...... nic graft-versus-host disease.
@en
Programmed death-1 pathway in ...... nic graft-versus-host disease.
@nl
prefLabel
Programmed death-1 pathway in ...... nic graft-versus-host disease.
@en
Programmed death-1 pathway in ...... nic graft-versus-host disease.
@nl
P2093
P356
P1476
Programmed death-1 pathway in ...... nic graft-versus-host disease.
@en
P2093
Hideaki Fujiwara
Hideo Yagita
Hisakazu Nishimori
Ken-Ichi Matsuoka
Koichiro Kobayashi
Mitsune Tanimoto
Miyuki Azuma
Nobuharu Fujii
Takehiro Tanaka
Yoshinobu Maeda
P304
P356
10.4049/JIMMUNOL.1400954
P407
P577
2014-07-30T00:00:00Z